We are always evolving in an ever-changing industry.

Keep up-to-date with PrECOG by visiting our news page regularly.

PrE0404 – Active

Now Open to Enrollment: PrE0404 A Phase I/II Study of Ixazomib and Ibrutinib in Relapsed/Refractory Mantle Cell Lymphoma. NCT03323151